Clinical Trials · NCT07769047
Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Mayo Clinic
- Enrollment
- 50
- Start date
- Sep 2026
- Locations
- 1 site, United States
- Primary endpoint
- Change in PWV between arms (Aim 1)